Cite

Fig 1

Erythrocyte population with phenotype typical for paroxysmal nocturnal haemoglobinuria
Erythrocyte population with phenotype typical for paroxysmal nocturnal haemoglobinuria

Fig 2

Population of monocytes and granulocytes with phenotype typical for paroxysmal nocturnal haemoglobinuria
Population of monocytes and granulocytes with phenotype typical for paroxysmal nocturnal haemoglobinuria

Evolution of PNH population before and after treatment with eculizumab

PNH population 27/10/20 16/3/21 23/11/21
Granulocyte 82.8% 85.3% 85.5%
Monocyte 78.6% 83.6% 82.7%
Erythrocyte 55.2% 57.4% 55.4%

The oscillation of biochemical parameter after eculizumab treatment

Date TBIL (μmol/l) AST (μkat/l) LD (μkat/l) ERY (1012/L) RET (1012/L)
12/01/21 84.6 0.44 4.76 4.45 369
04/03/21 67.9 2.36 24.98 4.09 185.7
16/03/21 61.2 0.52 4.64 4.45 239.2
06/07/21 54.2 0.81 7.66 3.8 363.5
16/09/21 90.9 0.48 3.79 4.55 232.9
09/12/21 79.1 1.96 13.93 4.87 194.3

Laboratory result during attack of haemolysis

Laboratory result
Haemoglobin 130 (g/L)
MCV 98.9 (fL)
Reticulocyte absolute count 225.9 (1012/L)
Reticulocyte relative count 5.7 (%)
Ferritin 275.30 (μg/l)
Lactate dehydrogenase 68 (μkat/L)
Haptoglobin 0.08 (g/l)
Direct bilirubin 81.1 (μmol/l)
Indirect bilirubin 9.5 (μmol/l)

Indication for screening for paroxysmal nocturnal hemoglobinuria

1. Chronic Coombs negative intravascular haemolysis with LD elevated above 1.5 UNL, decreased haptoglobin or kidney injury

2. Thrombosis in atypical location, or thrombosis in a young patient without other explanation and sings of haemolysis

3. Dysphagia, abdominal pain, erective dysfunction and sing of haemolysis

4. Signs of haemolysis and iron deficiency

5. Patient with aplastic anaemia or myelodysplastic syndrome

6. Idiopathic cytopenia without other explanation

Differential diagnosis of paroxysmal nocturnal haemoglobinuria

1. Haemolytic anaemia
1.1. Autoimmune haemolytic anaemia
1.2. Drugs induce haemolytic anaemia
1.3. Intoxication
1.4. Enzymopathies
1.4.1. G6PD deficiency
1.4.2. Pyruvate kinase deficiency
1.5. Hemoglobinopathies
1.5.1. Sickle cell anaemia
1.5.2. Thalassemia
1.6. Membranopaties
1.6.1. Spherocytosis
1.6.2. Elliptocytoses
1.7. Infections (malaria, HIV)
1.8. Microangiopathies
1.8.1. TTP
1.8.2. HUS
1.8.3. HELLP
1.8.4. Uremic syndrome
1.8.5. DIC
1.8.6. Drug induced macroangiopathic haemolytic anaemia
1.9. Systemic diseases
1.9.1. Systemic Lupus erythematosus
1.9.2. Vasculitis
2. Thromboembolic events with atypical localized thrombus
3. Bone marrow diseases
3.1. Myelodysplastic syndrome
3.2. Aplastic anaemia

Frequency of symptoms in patients with proximal nocturnal hemoglobinuria

Symptoms Frequency
Fatigue 80%
Dyspnoea 64%
Headache 63%
Hemoglobinuria 62%
Icterus 50%
Abdominal pain 50%
Erective dysfunction 38%
Chest pain 33%
Dysphagia 25%
eISSN:
1338-4139
Idioma:
Inglés
Calendario de la edición:
3 veces al año
Temas de la revista:
Medicine, Clinical Medicine, Internal Medicine, Cardiology